The successful candidate will be a member of the Genomic Medicine Drug Product Development group within Injectable DPD. This individual will have a direct impact on a dynamic and growing group of scientists and engineers developing adeno-associated virus (AAV) based gene therapy products within the larger Alexion Rare Disease Business Unit organization.
This team member will implement studies for the development of AAV formulations, fill-finish processes, and clinical device compatibility to ensure clinical and commercial readiness.
You will be responsible for:
Subscribe to job alerts and upload your resume!
*By registering with our site, you agree to our
Terms and Privacy Policy.